Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemofiltration in heart failure.

G Marenzi1, P Agostoni

  • 1Centro Cardiologico Monzino, IRCCS, Institute of Cardiology, University of Milan, Milan, Italy. giancarlo.marenzi@ccfm.it

The International Journal of Artificial Organs
|January 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension.

Pulmonary circulation·2022
Same author

Beta-blockers in pulmonary arterial hypertension: Time for a second thought?

Vascular pharmacology·2022
Same author

Debris production in bovine bone during implant site preparation. A comparative <i>in vitro</i> study: ultrasonic and drilling procedures.

Journal of biological regulators and homeostatic agents·2021
Same author

Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652].

International journal of cardiology·2021
Same author

The Coronary Sinus Reducer; 5-year Dutch experience.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2020
Same author

Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the ReCre8 trial.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2020

Hemofiltration effectively treats severe congestive heart failure (CHF) by removing edema, improving hemodynamics, and reducing neurohormonal activation. This intervention interrupts CHF progression and improves patient functional class.

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Severe congestive heart failure (CHF) often involves significant edema and neurohormonal activation.
  • Diuretic resistance can limit treatment options in advanced CHF.
  • Over-hydration, particularly pulmonary edema, impairs functional capacity in moderate CHF.

Purpose of the Study:

  • To evaluate the efficacy of hemofiltration in managing severe and moderate congestive heart failure (CHF).
  • To assess the impact of hemofiltration on clinical, hemodynamic, and neurohormonal parameters in CHF patients.
  • To compare the effects of hemofiltration with diuretics in specific CHF populations.

Main Methods:

  • Hemofiltration was employed to remove excess fluid and edema in patients with severe CHF.

Related Experiment Videos

  • Hemofiltration was also applied to patients with moderate CHF (NYHA classes II and III) experiencing pulmonary congestion.
  • Key clinical, hemodynamic, and laboratory parameters were monitored before and after treatment.

    • Main Results:

    • Hemofiltration led to significant clinical and hemodynamic improvements in severe CHF.
    • Treatment corrected hyponatremia, restored urine output, and reduced diuretic resistance.
    • Neurohormonal activation decreased, interrupting CHF progression and improving functional class.
    • In moderate CHF, hemofiltration effectively reduced lung water, improving clinical status and exercise capacity.

    Conclusions:

    • Hemofiltration is a valuable therapeutic option for severe CHF, reversing clinical deterioration and improving hemodynamics.
    • The procedure effectively manages fluid overload in moderate CHF, offering benefits beyond traditional diuretic therapy.
    • Hemofiltration interrupts the progression of CHF towards refractoriness and improves overall patient outcomes.